Ignite Creation Date:
2024-05-06 @ 2:21 AM
Last Modification Date:
2024-10-26 @ 11:17 AM
Study NCT ID:
NCT02021292
Status:
COMPLETED
Last Update Posted:
2020-06-04
First Post:
2013-12-20
Brief Title:
Clinical Study to Assess the Efficacy Safety and Tolerability of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension
Sponsor:
Actelion
Organization:
Actelion
Study Overview
Official Title:
Prospective Randomized Placebo-controlled Double-blind Multicenter Parallel-group 24-week Study to Assess the Efficacy Safety and Tolerability of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension
Status:
COMPLETED
Status Verified Date:
2020-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MERIT-1
Brief Summary:
Study to evaluate if macitentan is efficient safe and tolerable enough to be used for treatment of inoperable chronic thromboembolic pulmonary hypertension CTEPH
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None